The Nifty Pharma index was down 1.32% in early trade at 25,747.60, with all 19 constituents trading in the red as investors reassessed the potential long-term impact of higher US tariffs on Indian drug exporters.
The Nifty Pharma index was down 1.32% in early trade at 25,747.60, with all 19 constituents trading in the red as investors reassessed the potential long-term impact of higher US tariffs on Indian drug exporters.
<iframe src="https://hindustansphere.com/embed/cluster/be50aefad42892174f6d634bbb1e8a9f5d3fffb6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan"></iframe>
